InspireMD. has filed a patent for a shunting system that regulates blood flow from arteries to veins. The system includes easily separable housing components for access to inner components like a removable blood filter. The shunt comprises a first housing, regulator, and a second housing for blood egress. GlobalData’s report on InspireMD gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights InspireMD Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on InspireMD, Prosthetic cardiac valves was a key innovation area identified from patents. InspireMD's grant share as of January 2024 was 50%. Grant share is based on the ratio of number of grants to total number of patents.

Shunt system for regulating blood flow in circulatory system

Source: United States Patent and Trademark Office (USPTO). Credit: InspireMD Inc

The patent application (Publication Number: US20240033412A1) describes a shunt for blood transfer in a mammalian patient. The shunt comprises a first housing for receiving a first conduit for blood ingress, a regulator to control blood flow rate, and a second housing with a cavity for holding blood and a second conduit for blood egress. The shunt also includes a blood filter and a connector for removably attaching the first and second housings. The regulator is adjustable to control the rate of blood flow through the first conduit, with a trigger lever for adjustment.

Additionally, the patent application outlines a method for assembling the medical device and transferring blood in a mammalian patient using the described shunt. The method involves attaching the first and second conduits to the shunt, establishing a blood flow pathway between the conduits via the shunt, and regulating the blood flow by adjusting the regulator. The first conduit is placed in an arterial portion of the patient's circulatory system, while the second conduit is placed in a venous portion, allowing for efficient blood transfer. The method also includes steps for decreasing or increasing the size of the first conduit to regulate blood flow along the pathway. Overall, the patent application presents a detailed shunt design and method for blood transfer in medical settings, emphasizing control and efficiency in the process.

To know more about GlobalData’s detailed insights on InspireMD, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies